Year | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
Iran population | 87,406,253 | 88,455,128 | 89,516,589 | 90,590,788 | 91,677,878 |
men population | 43,703,126 | 44,227,564 | 44,758,295 | 45,295,394 | 45,838,939 |
mCRPC patients | 3,846 | 3,892 | 3,939 | 3,986 | 4,034 |
enzalutamide market share | 0.05 | 0.1 | 0.15 | 0.2 | 0.25 |
Scenario 1(without Enzalutamide) | 39,055,041 | 39,523,702 | 39,997,986 | 40,477,962 | 40,963,697 |
Scenario 2(with Enzalutamide) | 39,465,858 | 40,355,195 | 41,260,194 | 42,181,101 | 43,118,168 |
Financial impact | 410,817 | 831,493 | 1,262,208 | 1,703,139 | 2,154,470 |